NCT05192343 is a NA clinical trial of Virtual Reality and nature sounds in Women's Health, sponsored by Sümeyye BAL.

Who is sponsoring NCT05192343?

NCT05192343 is sponsored by Sümeyye BAL.

What drugs are being tested in NCT05192343?

Interventions in NCT05192343: Virtual Reality and nature sounds, nature sounds.

What condition does NCT05192343 study?

NCT05192343 studies Women's Health.

Is NCT05192343 still recruiting?

NCT05192343 is currently completed. Last updated 26 September 2023.

Last reviewed 2023-09-26 · How we verify

NCT05192343

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Virtual Reality and Nature Sounds on Pain and Anxiety During Hysterosalpingography

Completed NA Last updated 26 September 2023

What this trial tests

NA trial testing Virtual Reality and nature sounds in Women's Health in 135 participants. Completed in 15 August 2022.

Timeline

7 February 2022

Primary endpoint
25 April 2022

15 August 2022

Quick facts

Lead sponsor	Sümeyye BAL
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	135
Start date	7 February 2022
Primary completion	25 April 2022
Estimated completion	15 August 2022
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Virtual Reality and nature sounds
nature sounds

Conditions studied

Women's Health — all drugs for Women's Health →

Sponsor

Sümeyye BAL

Who can join

Adults 18 to 50, female only, with Women's Health. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to demonstrate the effects of virtual reality and nature sounds on pain and anxiety during hysterosalpingography.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effects of virtual reality and nature sounds on pain and anxiety during hysterosalpingography: a randomized controlled trial.
Baltaci N, Bal S, Koç E, Edis EK. · · 2024 · cited 3× · PMID 39166658 · DOI 10.1590/1806-9282.20231599

Verify or expand the search:

Other recruiting trials for Women's Health

Currently open trials in the same condition.

NCT05910580 — Improving Alcohol and Substance Use Care Access, Outcome, Equity During the Reproductive Years · NA · recruiting
NCT07003789 — Co-Developing an HIV Prevention Program for Women in Ghana · NA · active not recruiting
NCT06212349 — Therapeutic-educational Physiotherapy on Pain, Physical-functionality and Quality of Life in Women With Endometriosis. · NA · recruiting

Other Sümeyye BAL trials

Trials by the same sponsor.

NCT04676932 — Hysterosalpingography and Comfort Theory · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05192343 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sümeyye BAL
Last refreshed: 26 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05192343.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing